Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immune Thrombocytopenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07268898
What this trial is testing

National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients

Who this might be right for
Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China 500
Large-scale testing (Phase 3)Study completedNCT02868099
What this trial is testing

Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Kyowa Kirin China Pharmaceutical Co., Ltd. 203
Testing effectiveness (Phase 2)Looking for participantsNCT06929299
What this trial is testing

A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Jiangsu BioJeTay Biotechnology Co., Ltd. 56
Not applicableStudy completedNCT04943042
What this trial is testing

An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP

Who this might be right for
Immune ThrombocytopeniaITP
Swedish Orphan Biovitrum 199
Large-scale testing (Phase 3)UnknownNCT05685420
What this trial is testing

Extension Study of Herombopag for Pediatric Patients With Chronic Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd. 117
Early research (Phase 1)Study completedNCT03951623
What this trial is testing

The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients

Who this might be right for
Immune Thrombocytopenia (ITP)
Hutchison Medipharma Limited 45
Testing effectiveness (Phase 2)Study completedNCT05757570
What this trial is testing

An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias (RUBY-4)

Who this might be right for
Idiopathic Thrombocytopenic PurpuraImmune ThrombocytopeniaWarm Autoimmune Hemolytic Anemia+1 more
Alpine Immune Sciences Inc, A Subsidiary of Vertex 30
Testing effectiveness (Phase 2)Study completedNCT04917679
What this trial is testing

Eltrombopag Plus Diacerein vs Eltrombopag in Adult ITP

Who this might be right for
Thrombocytopenia
Qilu Hospital of Shandong University 102
Not applicableStudy completedNCT02287649
What this trial is testing

Polymorphism and Auto-reactive B and T Cells Subsets in Adult's Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Assistance Publique - Hôpitaux de Paris 45
Large-scale testing (Phase 3)UnknownNCT05328804
What this trial is testing

Herombopag + rhTPO in Severe Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Yin Jie 90
Testing effectiveness (Phase 2)WithdrawnNCT01976195
What this trial is testing

High-dose Dexamethasone Combining Thalidomide Versus Dexamethasone Mono-therapy for Management of Newly-diagnosed ITP

Who this might be right for
Immune Thrombocytopenia
Shandong University
Early research (Phase 1)Not Yet RecruitingNCT07315373
What this trial is testing

Optimal Dose of Zanubrutinib to Treat Adult Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07687134
What this trial is testing

Eltrombopag Plus Telitacicept vs. Eltrombopag Alone for Steroid-refractory/Relapsed ITP

Who this might be right for
Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 40
Post-approval studies (Phase 4)UnknownNCT05522465
What this trial is testing

Short-course High-dose Prednisone and Dexamethasone in Children With ITP

Who this might be right for
Immune ThrombocytopeniaGlucocorticoidsChild, Only
Fujian Medical University Union Hospital 608
Not applicableStudy completedNCT01933035
What this trial is testing

Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.

Who this might be right for
Immune ThrombocytopeniaChemotherapy Induced ThrombocytopeniaMyelodysplasia+1 more
Beth Israel Medical Center 50
Testing effectiveness (Phase 2)Ended earlyNCT02566603
What this trial is testing

PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Protalex, Inc. 15
Post-approval studies (Phase 4)Looking for participantsNCT04518475
What this trial is testing

Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China 224
Testing effectiveness (Phase 2)UnknownNCT05333744
What this trial is testing

The Combination of Prednisone and Recombinant Human Thrombopoietin for Treatment of Immune Thrombocytopenia in Pregnancy

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 90
Testing effectiveness (Phase 2)Looking for participantsNCT07362199
What this trial is testing

Anti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 20
Large-scale testing (Phase 3)Study completedNCT00344149
What this trial is testing

Rituximab as Second Line Treatment for ITP

Who this might be right for
Immune Thrombocytopenia (ITP)
Ostfold Hospital Trust 112
Next Page